Express Delivery
All orders are shipped with Speedy
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
MOTS-c is a peptide molecule identified by Dr. Ping Ling and a research team from the University of Southern California. It originates from mitochondria—the cellular structures centrally involved in energy production and regulation within the cell.
MOTS-c is a relatively new subject of scientific interest and continues to be actively studied to clarify its biological functions more precisely. In published literature, the peptide is considered a mitochondrially-encoded signaling molecule associated with metabolic regulation, energy balance, mitochondrial activity, and cellular adaptation to various stressors.
One of the most frequently discussed aspects of MOTS-c is its role in metabolic control. In experimental models, observations of improved glucose tolerance, increased insulin sensitivity, and influence on cellular mechanisms involved in energy metabolism and metabolic homeostasis have been reported.
In publications related to Cell Metabolism, MOTS-c has been described as a mitochondrial peptide that can activate key metabolic pathways and participate in the regulation of glucose homeostasis. In experimental models, improvements in metabolic control, physical endurance, and cellular response to energy stress have been observed.
Further research considers MOTS-c as a signaling molecule that can communicate with various cells and tissues. In this context, the peptide is being studied in relation to mitochondrial activity, inflammatory processes, cellular adaptation, and mechanisms associated with aging.
In some scientific sources, MOTS-c is described with exemplary experimental protocols of around 2.5 mg once every 5 days. These data are presented for informational purposes only and do not constitute a recommendation for use.
Example concentrations for 10 mg / 2 ml solution:
0.3 ml = 1.5 mg
0.4 ml = 2 mg
0.5 ml = 2.5 mg
0.6 ml = 3 mg
Currently, there is insufficient large-scale clinical data to allow a full assessment of the safety profile in humans. In limited observations, mild and transient adverse reactions such as:
Due to the limited volume of human data, no definitive conclusions can be drawn regarding long-term safety, optimal quantities, or effectiveness in various conditions.
The information is summarized based on available scientific publications and is for educational purposes only. It should not be used for diagnosis, treatment, or prevention of diseases.